Dr. Myzak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Sidney Kimmel Comprehensive Cancer Center
Rochester, MN 55905Phone+1 410-614-4459
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2010 - 2013
- University of Vermont College of MedicineClass of 2010
Certifications & Licensure
- MN State Medical License 2016 - 2020
- MD State Medical License 2013 - 2017
- OR State Medical License 2012 - 2015
Publications & Presentations
PubMed
- 61 citationsOlaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.Mark Yarchoan, Melinda C. Myzak, Burles A. Johnson, Ana De Jesus-Acosta, Dung T. Le
Oncotarget. 2017-04-19 - 212 citationsSulforaphane Retards the Growth of Human PC-3 Xenografts and Inhibits HDAC Activity in Human SubjectsMelinda C. Myzak, Philip Tong, Wan-Mohaiza Dashwood, Roderick H. Dashwood, Emily Ho
Experimental Biology and Medicine. 2007-02-01 - 70 citationsDietary Agents as Histone Deacetylase InhibitorsMelinda C. Myzak, Emily Ho, Roderick H. Dashwood
Molecular Carcinogenesis. 2006-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: